Omada Health (NASDAQ:OMDA) CFO Steven Cook Sells 2,600 Shares

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 2,600 shares of the company’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $19.02, for a total value of $49,452.00. Following the completion of the transaction, the chief financial officer directly owned 166,659 shares in the company, valued at approximately $3,169,854.18. The trade was a 1.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Omada Health Stock Up 10.5%

Omada Health stock opened at $20.89 on Friday. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92. The stock has a 50-day moving average price of $16.51 and a 200 day moving average price of $14.85. The company has a market capitalization of $1.24 billion and a price-to-earnings ratio of -77.37.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. Research analysts anticipate that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on OMDA. Morgan Stanley restated an “overweight” rating and issued a $30.00 target price on shares of Omada Health in a research note on Monday. Canaccord Genuity Group set a $24.00 target price on shares of Omada Health in a report on Friday, May 8th. Wall Street Zen upgraded shares of Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday. BMO Capital Markets decreased their price objective on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Finally, JPMorgan Chase & Co. cut their price target on Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a research note on Thursday, March 12th. Ten research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $22.91.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of OMDA. Quarry LP purchased a new stake in Omada Health during the 4th quarter worth approximately $29,000. TD Waterhouse Canada Inc. purchased a new position in Omada Health in the 4th quarter valued at $32,000. Raymond James Financial Inc. purchased a new stake in shares of Omada Health during the second quarter worth $32,000. Inlight Wealth Management LLC purchased a new position in shares of Omada Health in the fourth quarter worth about $45,000. Finally, Strs Ohio grew its stake in Omada Health by 151.0% during the 4th quarter. Strs Ohio now owns 4,267 shares of the company’s stock valued at $67,000 after acquiring an additional 2,567 shares in the last quarter.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.